Skip to Main Content

Paper Details

A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i).
Cardiol Ther
5
2020
Author NameAffiliation
Tara I ChangStanford University School of Medicine
Tara I ChangStanford Diabetes Research Center, Stanford University School of Medicine
Kenneth W MahaffeyStanford Center for Clinical Research, Stanford University School of Medicine
Kenneth W MahaffeyStanford Diabetes Research Center, Stanford University School of Medicine
  • 1 - 4

Datasets

Release 1.2